NEW YORK - Nukkleus Inc. (NASDAQ: NUKK), a $53.37 million market cap company whose stock has surged over 1,000% in the past six months according to InvestingPro data, has announced a strategic ...

EST Nukkleus (NUKK) up 11% afterhours at $28.47 on Translink pactInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to ...

Nukkleus (NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense ...

AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, ...

Nukkleus Inc. (NASDAQ: NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense sector, leveraging Translink's extensive expertise in mergers and ...

Nukkleus Inc. (NASDAQ: NUKK) is proud to announce the appointment of Brigadier General (Ret.) Mark Beesley as Strategic ...

Beesley on Joining Nukkleus "Joining Nukkleus is an exciting opportunity to bring my experience from both military and civilian roles to a company that's driving innovation and growth in strategic ...

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do. Nukkleus Inc. (NASDAQ: NUKK) experienced a sharp increase in its stock price ...

Nukkleus, Inc., an American digital technology company, has acquired a 51% controlling stake in Israeli startup finance company Star 26 Capital Inc. This is reported in the Nukkleus press release.

Nukkleus Leverages Strategic Acquisition to Support Rising Demand Five weeks ago, Nukkleus announced its proposed acquisition of a 51% stake in Star 26 Capital Inc., which owns Rimon—an exclusive ...